News Tagged ‘Alfa’

Mesothelioma drug maker Alfacell looks for buyer

Alfacell, manufacturer of the leading mesothelioma drug ONCONASE, has announced that it has hired financial advisor Oppenheimer & Co. to assist in the company’s “pursuit of available strategic alternatives to enhance shareholder value,” including a possible sale of the company.

Read the rest of this entry »

Mesothelioma Drug Fails Trial

SAN FRANCISCO (Thomson Financial) – Alfacell Corp. late Wednesday said results from its Phase IIIB clinical trial for Onconase, which was being studied as a potential treatment for unresectable malignant mesothelioma, didn’t meet the trial’s primary endpoint.

Read the rest of this entry »